Today, I want you to think bigger than just battery stocks.
Yes, I fully understand that Tesla purchases roughly 3.8 GWh of lithium-ion battery cells every year from Panasonic. Those cells are sent over from Japan and assembled at Tesla’s California factory.
However, the company’s Gigafactory is a game changer — and everyone knows it!
Within five years, the company expects to produce approximately 50 GWh in annual battery production. If production begins in 2017, it should only take about three years to reach full production.
Panasonic may have its benefits from supplying Tesla’s Gigafactory, but you’d be hard-pressed to find another solid battery stock after Musk’s expansion into the energy storage market.
Take your pick: Samsung, LG Chem, GS Yuasa… all of them will be directly competing against Elon Musk, and that’s not a good side to be on.
Besides, there’s a much better place to bank your first 10-bagger…
Bank Your First 10-Bagger from Elon’s Greed
First, I want you to understand that the real opportunity in Musk’s energy revolution can be summed up in one investment mantra: supply, supply, supply!
It really is that simple.
Two weeks ago, I told you exactly what would fuel Elon Musk’s lithium revolution. And after watching Tesla’s shares explode over the last five years, individual investors like us that didn’t buy back then can’t help but feel as if we’ve missed the boat.
Had you put a dime in Musk’s company three years ago, you would be smiling all the way to the bank:
Click Chart to Enlarge
But like I just said, I want you to look beyond battery stocks.
The bottom line for finding the right lithium play may come down to one crucial factor: location.
And the best part is that we already know the answer to where Tesla has set up shop.
Last year, the company broke ground on a site outside of Reno, Nevada.
It also has lithium producers in the area in a feverish frenzy. On July 15th, Albemarle Corp. shelled out $6.2 billion in cash and stock for Rockwood Holdings — the largest lithium producer.
The lithium market always reminds me of oil. Just as a handful of national oil companies control an overwhelming amount of the world’s crude supply, so too do a small group of lithium producers control the global lithium supply.
Just four companies account for 90% of the lithium market!
I know that sounds daunting for smaller companies hoping to get a piece of the action from Tesla’s Gigafactory — at least, until you take a deeper look into this situation.
Our analysts have traveled the world over, dedicated to finding the best and most profitable investments in the global energy markets. All you have to do to join our Energy and Capital investment community is sign up for the daily newsletter below.
Think Bigger Than Battery Stocks
When Tesla announced it purchased 1,000 acres outside of Reno in 2014, my excitement over potential lithium plays surged. However, that bullishness soared even higher as Elon Musk tripled Tesla Motors’ land holdings in Nevada over the past few months.
Yet even as my excitement grew, let me be perfectly clear — it wasn’t over those four mammoth lithium producers.
Musk has said it plain and clear: He’ll be giving priority to these North American lithium companies.
And although major North American lithium producers like FMC Corp. (NYSE: FMC) and Albemarle (NYSE: ALB) are in limited talks to help supply lithium to Tesla, there’s a much more lucrative opportunity out there.
Maybe it’s time you jumped on board of the runaway bull market for lithium.
Until next time,
Keith Kohl
Check us out on YouTube!A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of Energy & Capital, as well as the investment director of Angel Publishing’s Energy Investor and Technology and Opportunity.
For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology.
Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s Topline Trader advisory newsletter.
